18 November 2011


Justin Schack

Managing Director

Joe Gawronski

President and COO

Rosenblatt Securities Inc.
New York +1 212 607 3100
Dublin +353 1 855 9125

Inquiries to

NYX, DB1 Offer Remedies to EU: Quick Thoughts

The News

DB1 and NYX today announced that they submitted yesterday a remedy proposal, in connection with their proposed merger, to the European Commission’s Directorate General for Competition. As part of its review of the deal the DG, as expected, on October 5 issued a formal “statement of objections” outlining its concerns about the deal’s impact on competition. The companies’ remedy proposal is designed to address those concerns, which reportedly are focused on derivatives trading and clearing.

more newsletters »